Tocqueville Asset Management L.P. Intellia Therapeutics, Inc. Transaction History

Tocqueville Asset Management L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 30, 2019	SELL	$12.79 - $17.62 $197,605 - $272,229	-15,450 Closed	0 $0
Q4 2018 Feb 08, 2019	SELL	$11.39 - $27.13 $45,560 - $108,520	-4,000 Reduced 20.57%	15,450 $211,000
Q3 2018 Nov 13, 2018	BUY	$25.78 - $32.6 $10,312 - $13,040	400 Added 2.1%	19,450 $557,000
Q2 2018 Aug 13, 2018	BUY	$20.02 - $30.79 $381,381 - $586,549	19,050 New	19,050 $521,000

316

91.7M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $722M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.